content top

Choroidal Neovascular Membrane in Children

SCIENTIFIC POSTER 2016_Choroidal Neovascular Membrane in Children Maha M. Elshafei Case 1: A case of seven-year-old girl who presented to the eye clinic complaining of decreased vision in both eyes. Examination showed bilateral active choroidal neovascular membrane in the macular area, which was, treated with multiple intravitreal injections of Ranibizumab. Screening of the family showed bilateral Vitilliform maculopathy in the younger...

Read More

Wet AMD After Vitrectomy for RD

Presentation shows two cases of choroidal neovascularisation after vitrectomy. Both cases undergo two surgical procedures. In first case the second procedure was performed to remove epiretinal membrane which causes macular edema. Second case was PVR detachment surgery treated in two operations. In first procedure we attached retina with silicone oil tamponade and 180 degrees retinectomy, and in second one we peel membranes and remove...

Read More

Monthly Alternating Injections of Aflibercept and Bevacizumab for Wet AMD

June Gone Kim_SCIENTIFIC POSTER 2015 Purpose: Every 2-months after 3 initial monthly doses had been used as a standard regimen of intravitreal aflibercept for the treatment of wet AMD. In clinical practice, however, bimonthly aflibercept is insufficient for the maintenance in some cases. This study was designed to investigate the efficacy of monthly alternating injections of aflibercept and bevacizumab for maintenance treatment of wet...

Read More

Refractory Subfoveal Subretinal Fluid in Neovascular ARMD: Is There a Protective Effect on Good Visual Acuity?

Purpose: To investigate the functional outcome of eyes with neovascular age-related macular degeneration (nAMD) treated with ranibizumab which retain good visual acuity despite chronic, persistent subretinal fluid (SRF). Methods: This retrospective, interventional case series included 12 eyes of 11 patients with nAMD which have (mean age, 70.2 years; range, 58 to 78 years) persistent SRF despite anti-VEGF therapy, and good long-term visual...

Read More

Problems of Anti-VEGF Therapy in Massive Subretinal Hemorrhage in Wet AMD

Actuality: In most cases, the period and the gradual reduction of visual acuity in AMD allows patients to adapt to low vision without a sudden loss of central vision and independence. In case of a massive subretinal hemorrhage on the basis of AMD, patients experience sudden loss of central vision and the associated debasement in the quality of life. A-VEGF therapy in the treatment of subretinal hemorrhage, appears ambiguous. Changes in...

Read More

Six Months Results of Aflibercept versus Ranibizumab for Treatment of Wet-AMD

Oh Jae Kim_SCIENTIFIC POSTER 2015 Purpose: To compare the six-month clinical results of ranibizumab with aflibercept for the treatment of wet age-related macular degeneration (wet-AMD). Methods: Medical records of 44 eyes of 44 patients who underwent intravitreal ranibizumab (0.5mg / 0.05ml) or aflibercept (2.0mg / 0.05ml) injection for wet-AMD with more than 6 months of follow-up were reviewed retrospectively. All patients were treated...

Read More
content top